Adrianus C M Boon
Overview
Explore the profile of Adrianus C M Boon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
94
Citations
3982
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kumar J, Xu M, Li Y, You S, Doherty B, Gardiner W, et al.
ACS Sens
. 2025 Feb;
PMID: 39982783
Airborne transmission via aerosols is a dominant route for the transmission of respiratory pathogens, including avian H5N1 influenza A virus and bacteria. Rapid and direct detection of respiratory pathogen aerosols...
2.
Bamunuarachchi G, Najera F, Aziati I, Palmer J, Biro E, Wang D, et al.
Vector Borne Zoonotic Dis
. 2025 Feb;
PMID: 39950953
Bourbon virus (BRBV) is an emerging pathogen that can cause severe and fatal disease in humans. BRBV is vectored by (lone star ticks), which are widely distributed across the central,...
3.
Quinones-Parra S, Gras S, Nguyen T, Farenc C, Szeto C, Rowntree L, et al.
Sci Immunol
. 2025 Feb;
10(104):eadn3805.
PMID: 39919196
Cross-reactive αβ T cell receptors (TCRs) recognizing multiple peptide variants can provide effective control of rapidly evolving viruses yet remain understudied. By screening 12 naturally occurring influenza-derived HLA-B*35:01-restricted nucleoprotein (NP)...
4.
Trende R, Darling T, Gan T, Wang D, Boon A
Sci Adv
. 2025 Jan;
11(3):eads2927.
PMID: 39813353
The transmission bottleneck, defined as the number of viruses shed from one host to infect another, is an important determinant of the rate of virus evolution and the level of...
5.
Malladi S, Jaiswal D, Ying B, Alsoussi W, Darling T, Dadonaite B, et al.
bioRxiv
. 2024 Dec;
PMID: 39713327
SARS-CoV-2 mRNA vaccines induce robust and persistent germinal centre (GC) B cell responses in humans. It remains unclear how the continuous evolution of the virus impacts the breadth of the...
6.
Gnazzo V, Saleh H, Castro I, Boon A, Pinto A, Brien J, et al.
mBio
. 2024 Dec;
16(2):e0358924.
PMID: 39692514
A challenge in viral vaccine development is to produce vaccines that generate both neutralizing antibodies to prevent infection and cytotoxic CD8 T-cells that target conserved viral proteins and can eliminate...
7.
Case J, Sanapala S, Dillen C, Rhodes V, Zmasek C, Chicz T, et al.
Cell Host Microbe
. 2024 Nov;
32(12):2131-2147.e8.
PMID: 39561781
The continued emergence of SARS-CoV-2 variants and the threat of future Sarbecovirus zoonoses have spurred the design of vaccines that can induce broad immunity against multiple coronaviruses. Here, we use...
8.
Gnazzo V, Saleh H, Castro I, Boon A, Pinto A, Brien J, et al.
bioRxiv
. 2024 Nov;
PMID: 39553933
A challenge in viral vaccine development is to produce vaccines that generate both neutralizing antibodies to prevent infection and cytotoxic CD8 T-cells that target conserved viral proteins and can eliminate...
9.
Zychowski D, Bamunuarachchi G, Commins S, Boyce R, Boon A
Emerg Infect Dis
. 2024 Oct;
30(11):2396-2399.
PMID: 39387510
Bourbon virus is a tickborne virus that can cause human disease. Cases have been reported in Kansas, Oklahoma, and Missouri, USA. We identified Bourbon virus-specific neutralizing antibodies in patients from...
10.
Soudani N, Bricker T, Darling T, Seehra K, Patel N, Guebre-Xabier M, et al.
J Virol
. 2024 Sep;
98(10):e0052824.
PMID: 39230305
Importance: As SARS-CoV-2 continues to evolve, there is a need to assess the immunogenicity and efficacy of updated vaccines against newly emerging variants in pre-clinical models such as mice and...